All News

Disparities in health system performance were larger by income in the US, indicating a need for structural and systemic policy efforts.

The approval marks the first treatment for the rare disease marked by rapid and sustained weight gain caused by hypothalamic injury or dysfunction.

Expert guidance shows how to safely tailor aesthetic dermatology for allergic skin conditions like urticaria and eczema.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Rural US patients with breast cancer face higher advanced-stage diagnoses, with Black, Hispanic, uninsured patients and those in Southern regions at greatest risk.

Higher social vulnerability was associated with lower dietary fiber intake and a hostile gut microbiome in patients with melanoma or sarcoma receiving immune checkpoint blockade.

Rapid genetic test for IVF identifies FSHR variant in 60 minutes, guiding IVF hormone selection and improving in vitro fertilization success.

GLP-1s and SGLT2s were associated with improved kidney outcomes and no increased safety risks in patients with T1D and CKD.

A survey of marketplace enrollees revealed that they expect to cut back on basic household expenses to keep insurance coverage.

Patients with primary biliary cholangitis (PBC) can use linerixibat to address cholestatic pruritus, which up to 89% of patients with PBC experience.

A phase 3 clinical trial found that the ustekinumab biosimilar CT-P43 demonstrated equivalent efficacy, safety, and immunogenicity to reference ustekinumab in patients with moderate to severe plaque psoriasis.

The newly approved mosunetuzumab for relapsed/refractory follicular lymphoma improves clinic efficiency and patient experience, says Zahra Mahmoudjafari, PharmD, MBA, BCOP.

A new meta-analysis links menopausal hormone therapy to higher breast cancer risk with estrogen-progestin therapy, while estrogen-only therapy may lower risk.

New research shows that cardiovascular protection from GLP-1 receptor agonists such as semaglutide and tirzepatide diminishes within months of discontinuation.

Racial gaps in curative treatment for early-stage NSCLC persist among Medicare beneficiaries, with Black patients less likely to receive surgery.

Clonal hematopoiesis in chronic lymphocytic leukemia is widespread, shaping cytopenias, cardiovascular risk, and chemotoxicity.

Patients with multiple sclerosis valued both occupational therapy and physiotherapy as means of addressing their condition.

Study supports broader use of transient elastography to detect advanced liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease.

Icotrokinra is the first and only interleukin-23–targeted oral peptide approved for plaque psoriasis.

Smarter therapies, evolving frailty tools, and more inclusive trials are finally extending myeloma's survival gains to older adults.

A federal court blocked RFK Jr's vaccine agenda, freezing the ACIP shakeup and safeguarding child vaccine access as the legal fight over vaccines intensifies.

Subcutaneous mosunetuzumab simplifies the delivery of the bispecific therapy for patients with relapsed/refractory follicular lymphoma, says Zahra Mahmoudjafari, PharmD, MBA, BCOP.

Vaccine schedule shifts may widen gaps; learn how safety-net workflows and community education counter misinformation and boost uptake.

Long-term adherence to healthy behaviors reduces the risk of cardiovascular disease and type 2 diabetes, even among individuals taking antihypertensive medications.

The complete response letter marks the second time that reproxalap, a medication for use in dry eye disease, has been rejected by the FDA.

Study links PFAS and forever chemicals in children and teens to lower bone density in adolescents—especially girls—highlighting critical exposure windows.